One of a Kind

How Innovative Farmers are Tailoring Their Crop Protection

LEARN MORE
Man stands in front of a tractor with lines resembling a thumbprint over him
News from Bayer
December 13, 2024
Not intended for U.S. and UK Media
Acoramidis receives positive CHMP opinion for treatment of transthyretin amyloid cardiomyopathy
November 12, 2024
Third quarter of 2024
Bayer: Strategic progress in challenging business environment – Group outlook confirmed in nearly all parameters
October 19, 2024
Not intended for U.S. and UK Media
Long-term efficacy and safety profile of Eylea™ 8 mg with extended dosing intervals in diabetic macular edema confirmed at three years